Novel health economic evaluation of a vaccination strategy to prevent HPV-related diseases: the BEST study
GHDx Entry last modified on: Jan 31, 2023
HPV vaccines
Dataset Records for HPV vaccines
Displaying 301 - 350 of 377
Impact of Number of Human Papillomavirus Vaccine Doses on Genital Warts Diagnoses Among a National Cohort of U.S. Adolescents
GHDx Entry last modified on: Apr 14, 2022
The Health Technology Assessment of bivalent HPV vaccine Cervarix in Italy
GHDx Entry last modified on: May 30, 2020
Uptake of human papillomavirus vaccine among adolescent males and females: Immunization Information System sentinel sites, 2009-2012
GHDx Entry last modified on: Mar 14, 2022
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014-United States
GHDx Entry last modified on: Apr 14, 2022
Australia Immunisation Coverage Annual Report 2016
Annual Immunisation Coverage Report 2016
Report:
Subnationally representative
Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France
GHDx Entry last modified on: Jan 31, 2023
Marshall Islands Ministry of Health Annual Report 2010
Ministry of Health Republic of the Marshall Islands "Kumiti Ejmuur" Annual Report FY 2010
Report:
Discharge - Epi surveillance - Financial - Inpatient - Operational - Outpatient
Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium
GHDx Entry last modified on: Jan 31, 2023
Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway
GHDx Entry last modified on: Jan 31, 2023
Comparative cost-effectiveness of HPV vaccines in the prevention of cervical cancer in Malaysia
GHDx Entry last modified on: May 30, 2020
A cost-utility analysis of adding a bivalent or quadrivalent HPV vaccine to the Irish cervical screening programme
GHDx Entry last modified on: Jan 31, 2023
Ethnic background and human papillomavirus vaccine uptake in Denmark: A countrywide retrospective cohort study including 274,154 women aged 19-28 years
GHDx Entry last modified on: Mar 14, 2022
Cost-effectiveness analysis of prophylactic cervical cancer vaccination in Japanese women
GHDx Entry last modified on: Jan 31, 2023
Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls
GHDx Entry last modified on: Mar 14, 2022
Marshall Islands Ministry of Health Annual Report 2011
Report:
Financial - Inpatient - Operational - Outpatient
Progress toward implementation of human papillomavirus vaccination-the Americas, 2006-2010
GHDx Entry last modified on: Apr 14, 2022
HPV16/18 vaccination to prevent cervical cancer in The Netherlands: model-based cost-effectiveness
GHDx Entry last modified on: Jan 31, 2023
Cost-effectiveness of human papilloma virus vaccination in Iceland
GHDx Entry last modified on: Jan 31, 2023
Human papillomavirus vaccination of females in a large health claims database in the United States, 2006-2012
GHDx Entry last modified on: Mar 14, 2022
Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries
GHDx Entry last modified on: Jan 31, 2023
Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine
GHDx Entry last modified on: Mar 14, 2022
Effect of human papillomavirus vaccination on cervical cancer screening in Alberta
GHDx Entry last modified on: Mar 14, 2022
Economic evaluation of human papillomavirus vaccination in the United Kingdom
GHDx Entry last modified on: Jan 31, 2023
Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases
GHDx Entry last modified on: Mar 14, 2022
Socioeconomic predictors of human papillomavirus vaccination in Danish men - A nationwide study
GHDx Entry last modified on: Mar 14, 2022
Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States
GHDx Entry last modified on: May 30, 2020
Is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysis
GHDx Entry last modified on: May 30, 2020
Health and economic implications of HPV vaccination in the United States
GHDx Entry last modified on: May 30, 2020
Assessment of the cost-effectiveness of a quadrivalent HPV vaccine in Norway using a dynamic transmission model
GHDx Entry last modified on: Jan 31, 2023
Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland
GHDx Entry last modified on: Jan 31, 2023
Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
GHDx Entry last modified on: Jan 31, 2023
A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program
GHDx Entry last modified on: May 30, 2020
Rwanda Health Statistics Booklet 2012
Report:
Discharge - Epi surveillance - Financial - Inpatient - Outpatient - Subnationally representative
Rwanda Annual Health Statistics Booklet 2013
Report:
Discharge - Epi surveillance - Financial - Inpatient - Outpatient - Subnationally representative
Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands
GHDx Entry last modified on: Jan 31, 2023
The cost-effectiveness of a quadrivalent human papillomavirus vaccine in Taiwan
GHDx Entry last modified on: Jan 31, 2023
United States National Health and Nutrition Examination Survey 2005-2006
Survey:
Cross-sectional - Exam - Household - Individual - Interview - Nationally representative
Model for assessing human papillomavirus vaccination strategies
GHDx Entry last modified on: Jan 31, 2023
The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada
GHDx Entry last modified on: Jan 31, 2023
Mathematical models of cervical cancer prevention in Latin America and the Caribbean
GHDx Entry last modified on: Jan 31, 2023
CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors-United States, 2005-2013
GHDx Entry last modified on: Apr 14, 2022
Mathematical models of cervical cancer prevention in the Asia Pacific region
GHDx Entry last modified on: Jan 31, 2023
The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK
GHDx Entry last modified on: Jan 31, 2023
Cost-utility analysis of vaccination against HPV in Israel
GHDx Entry last modified on: May 30, 2020
Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: a transmission dynamic model-based evaluation
GHDx Entry last modified on: Jan 31, 2023
Subscribe